New insertion site for Nexplanon following safety concerns

The MHRA has amended its advice relating to the long-acting contraceptive implant Nexplanon (etonogestrel) following reports of neurovascular injury and implants migrating to the vasculature (including the pulmonary artery).

by Lisa Lytle
The new insertion site is in an area overlying the triceps muscle, a location generally free of major blood vessels and nerves. | SCIENCE PHOTO LIBRARY
The new insertion site is in an area overlying the triceps muscle, a location generally free of major blood vessels and nerves. | SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package